Accession Number: | 0000898432-20-000023 |
Date: | 2020-01-02 |
Issuer: | IRADIMED CORP (IRMD) |
Original Submission Date: |
JOHNSON BRENT
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-02 | A | 6,000 | a | $0.93 | 8,940 | direct | ||
COMMON STOCK | 2020-01-02 | S | 6,000 | d | $23.55 | 2,940 | direct | ||
COMMON STOCK | 2020-01-03 | A | 14,000 | a | $0.93 | 16,940 | direct | ||
COMMON STOCK | 2020-01-03 | S | 14,000 | d | $23.82 | 2,940 | direct | ||
COMMON STOCK | 2020-01-06 | A | 8,000 | a | $0.93 | 10,940 | direct | ||
COMMON STOCK | 2020-01-06 | S | 8,000 | d | $24.37 | 2,940 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2020-01-02 | deemed execution date | M | 6,000 (d) | 2022-11-01 | common stock 6,000 | $0.93 | 120,468 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2020-01-03 | deemed execution date | M | 14,000 (d) | 2022-11-01 | common stock 14,000 | $0.93 | 106,468 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2020-01-06 | deemed execution date | M | 8,000 (d) | 2022-11-01 | common stock 8,000 | $0.93 | 98,468 | direct |
ID | footnote |
---|---|
f1 | the exercises and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 5, 2019. |
f2 | this transaction was executed in multiple trades at prices ranging from $23.50 to $23.64. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f3 | this transaction was executed in multiple trades at prices ranging from $23.50 to $24.05. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f4 | this transaction was executed in multiple trades at prices ranging from $24.26 to $24.55. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f5 | this option, representing a right to purchase a total of 278,408 shares, was granted on november 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |